2GL-21999-51475
2 vaccinations
2 coded responses
14 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 209 / MD
- Registered
- 2021-03-23
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-02
Dose 1 — Pfizer-BioNTech
-
2021-03-23
Registered in v-safe
-
2021-03-23
Dose 2 — Pfizer-BioNTech
-
2021-03-23
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Abdominal painAdult check-in
-
2021-03-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to workAdult check-in
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Fatigue or tirednessAdult check-in
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Fatigue or tirednessAdult check-in
- 2021-03-29
- 2021-03-30
- 2021-04-07
- 2021-04-13
- 2021-04-22
- 2021-04-28
- 2021-05-04
-
2021-06-24
Survey response — 3 months, dose 2MedDRA: Bronchitis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: BronchitisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-24
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-02
-
2021-09-21
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2021-09-21
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-09-24
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-03-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Pfizer-BioNTech | |
| 2 | 2021-03-23 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-24 | Successful | Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2021-09-21 | Successful 2021-09-24 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 9 — 3 months, dose 2
Symptoms: Bronchitis
Release 9 — 6 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release